文献速递呼吸危重症与机械通气

程序化拔管后呼吸支持预防再插管:随机临床试验

Protocolized Postextubation Respiratory Support to Prevent Reintubation: A Randomized Clinical Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

在学术医学中心内科ICU开展务实性集群交叉试验,纳入751例有创机械通气拔管成人,比较程序化拔管后呼吸支持(疑高碳酸血症者无创通气、其余经鼻高流量氧疗)与常规护理。程序化组96小时内再插管15.9%,常规组13.3%(OR 1.23;95%CI 0.82–1.84;P=0.32),未降低再插管率。

要点

  • 程序化拔管后支持未降低96小时内再插管率(15.9% vs 13.3%,P=0.32)。
  • 差异主要来自经鼻高流量氧疗使用增加(74.7% vs 2.8%)。
  • 疑高碳酸血症者接受无创通气,其余接受经鼻高流量氧疗。

核心结论

  • 在学术医学中心内科ICU广泛危重成人中,以增加经鼻高流量氧疗使用为主的程序化拔管后呼吸支持未预防再插管。

主要发现

  • 程序化组359例中331例(92.2%)接受拔管后呼吸支持,常规组392例中66例(16.8%)接受,差异主要来自经鼻高流量氧疗(74.7% vs 2.8%)。
  • 程序化组57例(15.9%)再插管,常规组52例(13.3%),OR 1.23;95%CI 0.82–1.84;P=0.32。

关键数值与推荐

  • 主要结局为拔管后96小时内再插管。
  • 程序化方案:疑高碳酸血症者接受无创通气,非疑高碳酸血症者接受经鼻高流量氧疗。
  • 常规护理由治疗临床医生酌情决定拔管后管理。

临床怎么用

  • 对内科ICU拔管成人常规程序化使用拔管后呼吸支持(以经鼻高流量氧疗为主)未显示降低再插管率。
  • 临床决策仍需结合个体情况,不宜仅以预防再插管为目的普遍实施该程序化方案。

局限性

  • 研究在单一学术医学中心内科ICU进行,外推需谨慎。
  • 常规组经鼻高流量氧疗使用率低(2.8%),组间支持方式差异可能影响结果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Respiratory support (noninvasive ventilation or high-flow nasal cannula) applied at the time of extubation has been reported to reduce reintubation rates, but concerns regarding effectiveness have limited uptake into practice.Objectives: To determine if providing postextubation respiratory support to all patients undergoing extubation in a medical ICU would decrease the incidence of reintubation.Methods: We conducted a pragmatic, two-armed, cluster-crossover trial of adults undergoing extubation from invasive mechanical ventilation between October 1, 2017, and March 31, 2019, in the medical ICU of an academic medical center. Patients were assigned to either protocolized postextubation respiratory support (a respiratory therapist-driven protocol in which patients with suspected hypercapnia received noninvasive ventilation and patients without suspected hypercapnia received high-flow nasal cannula) or usual care (postextubation management at the discretion of treating clinicians). The primary outcome was reintubation within 96 hours of extubation.Measurements and Main Results: A total of 751 patients were enrolled. Of the 359 patients assigned to protocolized support, 331 (92.2%) received postextubation respiratory support compared with 66 of 392 patients (16.8%) assigned to usual care, a difference driven by differential use of high-flow nasal cannula (74.7% vs. 2.8%). A total of 57 patients (15.9%) in the protocolized support group experienced reintubation compared with 52 patients (13.3%) in the usual care group (odds ratio, 1.23; 95% confidence interval, 0.82 to 1.84; P = 0.32).Conclusions: Among a broad population of critically ill adults undergoing extubation from invasive mechanical ventilation at an academic medical center, protocolized postextubation respiratory support, primarily characterized by an increase in the use of high-flow nasal cannula, did not prevent reintubation compared with usual care.Clinical trial registered with www.clinicaltrials.gov (NCT0328831).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Casey JD, Vaughan EM, Lloyd BD, et al. Protocolized Postextubation Respiratory Support to Prevent Reintubation: A Randomized Clinical Trial. Am J Respir Crit Care Med. 2021. PMID: 33794131. doi:10.1164/rccm.202009-3561OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。